Valerie L. Pierce serves as Executive at NGM BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Valerie L. Pierce has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 5, 2024 involved transacting 26,458 shares valued at $0.
Valerie L. Pierce currently holds 55,374 shares of NGM BIOPHARMACEUTICALS INC (NGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Valerie L. Pierce has been a net neutral trader of NGM stock. They have purchased $0 and sold $0 worth of shares.
Valerie L. Pierce's most recent insider trade was on Apr 5, 2024, when they sold 26,458 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.34 |
| Discretionary |
| Mar 2, 2023 | NGM | $0 | Award | 49,000 | $N/A | Discretionary |